Table 3.
Persistence on medication in the fingolimod and iDMT matched cohorts
| Characteristics | Fingolimod cohort (n = 99) | Idmt cohort (n = 99) | p value | ||
|---|---|---|---|---|---|
| Patients persistent (n, % yes) | 82 | 82.80 % | 47 | 47.50 % | <0.0001 |
| Patients discontinued therapy (n, %) | 12 | 12.10 % | 36 | 36.40 % | <0.0001 |
| Patient switched to another DMT (n, %) | 5 | 5.10 % | 16 | 16.20 % | 0.0111 |
| Reasons for discontinuation (n, % total population) | |||||
| Insufficient efficacy | 2 | 2.00 % | 22 | 21.80 % | |
| Side effects | 10 | 9.90 % | 16 | 15.80 % | |
| Pregnancy/wish for child | 1 | 1.00 % | 2 | 2.00 % | |
| Patient wish | 3 | 3.00 % | 6 | 5.90 % | |
| Other | 1 | 1.00 % | 6 | 5.90 % | |